首页> 外文期刊>Medicine. >Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate
【24h】

Opsonic and Antibody Responses to Pneumococcal Polysaccharide in Rheumatoid Arthritis Patients Receiving Golimumab Plus Methotrexate

机译:类风湿关节炎患者接受戈利木单抗加甲氨蝶呤对肺炎球菌多糖的光和抗体反应。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Vaccination against Streptococcus pneumoniae is recommended for rheumatoid arthritis (RA) patients receiving immunosuppressive treatments. The objective of this study was to evaluate the humoral response to 23-valent pneumococcal polysaccharide vaccination (PPSV23) in RA patients receiving methotrexate (MTX) alone or in combination with a tumor necrosis factor inhibitor, golimumab (GOM).
机译:对于接受免疫抑制治疗的类风湿关节炎(RA)患者,建议接种抗肺炎链球菌疫苗。这项研究的目的是评估RA患者接受甲氨蝶呤(MTX)或与肿瘤坏死因子抑制剂golimumab(GOM)联合使用时对23价肺炎球菌多糖疫苗(PPSV23)的体液反应。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号